The best defibrillator to buy depends on who is using it and where it lives. For a home, office, or gym, the answer is an automated external defibrillator (AED) with dual adult/pediatric modes, voice-and-visual prompts, and a price between USD 1,200 and USD 2,500; the Heartsine 350P, Defibtech Lifeline, and Zoll AED Plus are the strongest all-round picks at that tier. For a patient with a documented ejection fraction at or below 35 percent, no consumer purchase is appropriate — an implanted cardioverter-defibrillator (ICD) is prescribed and placed by an electrophysiologist. Buying the wrong device for the wrong user wastes money and, in the worst case, costs a life.
What a defibrillator actually does inside the heart
A fibrillating heart is not a stopped heart. Its muscle fibers are contracting chaotically at 300 to 600 electrical events per minute, so the chambers quiver instead of pumping and cardiac output falls to near zero. Survival drops roughly 7 to 10 percent for every minute without defibrillation, which is the number that drives every design decision in the devices below.
Defibrillation works by delivering a synchronized pulse of stored energy that depolarizes a critical mass of heart muscle at once. That mass — commonly cited as 80 to 90 percent of ventricular tissue — forces every cell into the same refractory state simultaneously, so the chaotic wavelets have nowhere to propagate. The heart's natural pacemakers then resume. Biphasic waveforms, standard since the early 2000s, achieve this with 120 to 200 joules rather than the 200 to 360 joules monophasic devices required, which reduces myocardial damage per shock.
In plain terms: a defibrillator does not restart a heart. It stops a chaotic rhythm so the heart's own electrical system can restart itself.
Two device families exist under the same word. An AED is a public-access device that analyzes a rhythm automatically and advises a shock to a lay rescuer. An ICD is a surgically implanted device that monitors continuously and fires without any human decision. They are not interchangeable purchases, and mixing them up is the single most expensive mistake in this category.
The safety threshold: who should buy which device
The dividing line is clinical, not financial. Per the 2022 AHA/ACC/HFSA heart failure guideline, an ICD is indicated for primary prevention in patients with a left ventricular ejection fraction of 35 percent or less despite three months of optimal medical therapy and a life expectancy above one year. That 35 percent threshold is the number to reconcile with the 40 percent figure sometimes quoted for cardiac resynchronization eligibility — the two thresholds describe different interventions, and a patient can meet one without meeting the other.
For everyone else — homes, small businesses, schools, dental offices, gyms — the purchase is an AED. Roughly 70 to 80 percent of out-of-hospital cardiac arrests occur in homes, which is why the American Heart Association has repeatedly argued that home AED placement is defensible in households with a known cardiac risk, even though large trials have not proven a population-level mortality benefit.
| Buyer profile | Device type | Typical cost (USD) | Who acts in an emergency |
|---|---|---|---|
| Home with no known cardiac disease | Consumer AED | 1,200–1,800 | A family member or bystander |
| Gym, office, dental clinic | Public-access AED | 1,500–2,500 | Any trained staff member |
| EF ≤35% despite therapy | Prescribed ICD | 30,000–50,000 (device plus implant) | The device itself |
| Remote or vehicle use | Ruggedized AED | 1,800–2,800 | The responder on scene |
| Infant or child under 25 kg | AED with pediatric pads or attenuator | Add 80–200 to base | An adult responder |
That cost spread — a factor of roughly 20 between the cheapest AED and a full ICD implant — explains why consumer buying guides and clinical reviews read so differently. They are pricing different products.
How the leading AED models compare
The consumer AED market is small in manufacturer count and dominated by five companies. What separates models is not shock efficacy, since all cleared devices deliver the same biphasic waveform within a narrow range, but four practical variables: pad life, battery life, self-test frequency, and whether the device coaches CPR compressions.
| Model | Pad shelf life | Battery standby | CPR feedback | Public-access rating | Street price (USD) |
|---|---|---|---|---|---|
| Heartsine 350P | 4 years | 4 years | Metronome | High | 1,500–1,900 |
| Defibtech Lifeline | 2 years | 5 years | None | Moderate | 1,200–1,500 |
| Zoll AED Plus | 5 years | 5 years | Real-time depth feedback | High | 1,600–2,100 |
| Philips HeartStart FRx | 2 years | 4 years | None | High | 1,500–1,900 |
| Physio-Control Lifepak CR2 | 4 years | 4 years | Voice coaching | High | 2,000–2,600 |
The Zoll AED Plus is the only model in this table that measures actual compression depth and rate and corrects the rescuer in real time, using a sensor in the pad. That matters because the same 2020 AHA guidelines that set the shock algorithm also set compression depth at 2 to 2.4 inches and rate at 100 to 120 per minute — parameters that untrained bystanders miss by wide margins without feedback.
The Defibtech Lifeline wins on price and on the fact that its battery can be swapped by the owner without a service visit. The tradeoff is a two-year pad life, meaning a replacement cost of roughly USD 60 to 90 every two years on top of purchase.
The timelines that should drive your decision
Defibrillator purchase decisions are dominated by time in three separate clocks: the device's own maintenance clock, the patient's rescue clock, and the regulatory clearance clock. The first is the one buyers most often neglect.
| Timeline | Interval | Consequence if missed |
|---|---|---|
| Pad electrode expiration | 2–5 years from manufacture | Device refuses to shock |
| Battery replacement | 4–5 years, or per self-test alert | Device fails readiness check |
| AED self-test cycle | Daily to weekly, model-dependent | Silent failure between inspections |
| Manufacturer warranty | 5–8 years typical | Repair cost falls on owner |
| Cardiac arrest to first shock | Under 3–5 minutes for best survival | Survival falls 7–10% per minute |
| Post-shock rhythm recheck | 2 minutes, per AED prompts | Missed refibrillation |
| Post-arrest neurological assessment | 72 hours | Determines long-term prognosis |
A realistic owning cost is therefore higher than the sticker. Over an eight-year life, a USD 1,500 AED with two battery replacements at USD 150 each and four pad replacements at USD 75 each runs roughly USD 2,400 in total — a 60 percent premium over purchase price that should be budgeted at the outset.
Edge cases that change the purchase
Pediatric use is the most common edge case and the one most often mishandled. Children under roughly 25 kg, or under about 8 years old, should receive attenuated energy — typically 50 to 86 joules rather than 150 joules — delivered through pediatric pads or a pediatric attenuator key. Not every AED sold includes this. The Philips FRx requires a separately purchased pediatric key, while the Heartsine 350P ships with a pediatric mode built in. If the AED will serve a school or pediatric clinic, verify the attenuator is included before purchase, not after.
Implanted devices create a second edge case. A patient with an ICD who arrests may be shocked by their own device while a rescuer is placing AED pads. Current guidance is to place pads at least 8 inches from the implanted generator and to let the ICD do its work; the AED should not be withheld. The two devices can coexist on the same chest.
Water and metal are the third. A wet chest should be dried before pad placement, and pads should not touch each other or a transdermal medication patch. These are small details that appear in no marketing copy and in every device manual.
Common misconceptions about buying a defibrillator
The most persistent myth is that a defibrillator can be used on a flatline. It cannot. Asystole — a truly flat tracing — has no chaotic electrical activity to terminate, and a shock delivers nothing useful. Every modern AED analyzes the rhythm first and will refuse to charge if it detects asystole or a normal rhythm. The device protects the patient from the rescuer.
A second misconception is that a more expensive AED shocks better. All FDA-cleared AEDs deliver a biphasic waveform in the 120 to 200 joule range with first-shock efficacy above 90 percent in published studies, and no head-to-head trial has shown a mortality difference between brands. Price buys pad life, feedback, ruggedness, and warranty — not shock superiority. That is the corrected view most buying guides miss.
A third is that buying an AED satisfies a legal duty. Most US states offer Good Samaritan protection to lay rescuers, but requirements for AED registration with local EMS, signage, and trained responders vary by state and sometimes by municipality. A device in a closet with expired pads is a liability, not a defense.
Red-flag warnings before you buy:
- Pads past their expiration date, or a device that has not self-tested in 30 days
- A model with no pediatric attenuator if children are ever present
- A refurbished unit sold without a manufacturer warranty or battery history
- An AED placed more than a 3-minute round trip from where a collapse is likely
- A seller who cannot confirm FDA clearance of the specific model number
- Any device advertised as suitable for a patient with an ejection fraction under 35 percent instead of an ICD
What to actually do when choosing a device
Start with the user, not the device. Write down who will respond, how many people are on site, and whether children are ever present. That single exercise eliminates half the market.
Then match the model to the maintenance burden you will actually sustain. A device with five-year pads and a five-year battery costs more up front and less over a decade; a device with two-year pads is cheaper today and demands more attention. Neither is wrong, but the choice should be deliberate.
Register the device with the local EMS agency and with the manufacturer so recall notices reach you. Put the pad and battery expiration dates in a calendar with a two-month advance alert. Run one unannounced drill per year in which a staff member retrieves the device, opens it, and follows the prompts on a training manikin. A defibrillator that has never been opened in a drill is a decoration.
Finally, verify that anyone expected to respond holds current basic life support certification, renewed every two years. The device is the last link in a chain that begins with recognition and compressions, and a well-chosen AED cannot compensate for a rescuer who hesitates for 90 seconds before opening the case.
Limitations of this comparison
No consumer AED has been shown in a randomized trial to reduce mortality compared with another brand, and the evidence base for home AED placement specifically remains weaker than for public-access programs. Prices in this article reflect US street pricing as of late 2026 and vary by 15 to 25 percent between distributors. Clinical thresholds cited here apply to adults and do not cover congenital heart disease or certain inherited arrhythmia syndromes, where ICD indications differ and only an electrophysiologist can advise. This article is a purchasing framework, not medical advice; any decision about an implanted device belongs with a cardiologist who has reviewed the patient's ejection fraction, rhythm history, and comorbidities.